This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

Alexza expects US and European regulators to announce approval decisions in December.

Celsion: Run-Up Trade Into Thermodox Results

Traders are already bidding up shares of Celsion in anticipation of pivotal trial results.

Short Trade: Supernus IPO Lock-Up
Short Trade: Supernus IPO Lock-Up

10/31/12 - 07:00 AM EDT

Supernus share should fall now that 10 million shares under lock-up can now be sold.

How to Prep for the Inevitable Bursting of the Biotech Stock Bubble

Traders need to be less cocky and more prepared for when stocks fall.

AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades

The biotech bull market has created a new category of swing trade catalysts.

How to Trade Hemispherx Even If You Hate the Stock

Biotech swing trader Mark Messier warns to look at Hemispherx as a short-term trade, not an investment.

Zogenix: Three Shots At Run-Up Trade
Zogenix: Three Shots At Run-Up Trade

09/26/12 - 08:00 AM EDT

Get in Zogenix early before other traders start speculating over its chronic pain drug Zohydro.

Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results

Biotech trader Mark Messier explains how to position trades ahead of two important biotech clinical trials.

Dynavax: The BioRunUp Trade Into An FDA Panel

Biotech trader Mark Messier explains how to swing trade Dynavax into a Nov. 14 FDA advisory panel.

Page 2 of 2
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs